{"id":"W2898055118","doi":"10.1016/j.omtn.2018.10.004","title":"Identification of Novel Antisense-Mediated Exon Skipping Targets in DYSF for Therapeutic Treatment of Dysferlinopathy","year":2018,"lang":"en","type":"article","venue":"Molecular Therapy — Nucleic Acids","topic":"Caveolin-1 and cellular processes","field":"Biochemistry, Genetics and Molecular Biology","cited_by":75,"is_retracted":false,"has_abstract":true,"ca_institutions":"Muscular Dystrophy Canada; University of Alberta","funders":"Canadian Institutes of Health Research; Alberta Innovates; Ministry of Advanced Education and Technology; Canada Foundation for Innovation; BC Children’s Hospital Foundation; BC Children's Hospital; Muscular Dystrophy Canada; Children's Hospital Foundation; University of Alberta; Women and Children's Health Research Institute; Rare Disease Foundation; Faculty of Medicine and Dentistry, University of Alberta; Alberta Innovates - Health Solutions; Ministry of Advanced Education, Government of Alberta; Children's Health Research Institute","keywords":"Dysferlin; Exon; Exon skipping; Biology; Genetics; Mutation; Myopathy; Mutant; Duchenne muscular dystrophy; Dystrophin; Molecular biology; Gene; Alternative splicing","routes":{"ca_aff":true,"ca_fund":true,"ca_venue":false,"about_ca":false,"invisible_to_affiliation_only":false},"retraction":null,"screen":null,"direct_labels":[],"prediction":{"model_version":"codex-gemma-dda1882f352a","candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0001892583,0.000211369,0.0002889204,0.0001084426,0.00004550719,0.00001210045,0.0001840586,0.0001787174,0.00001263154],"category_scores_gemma":[0.00002998969,0.0001970261,0.0001655137,0.0001927156,0.0001657434,0.000006340018,0.00002267778,0.00003337821,0.000002749949],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.0000232947,"about_ca_system_score_gemma":0.00007591868,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.00002048901,"about_ca_topic_score_gemma":0.00001417955,"domain_scores_codex":[0.998708,0.00004265244,0.0004730147,0.0003808295,0.0001472956,0.0002482343],"domain_scores_gemma":[0.9990523,0.00001602025,0.0002290527,0.0004246183,0.0002343316,0.00004364571],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","study_design_scores_codex":[0.0004062088,0.0005923255,0.0007637608,0.00003898109,0.0001219973,0.000002173938,0.000363583,0.00002012225,0.9871703,0.00008390692,0.000005664265,0.01043098],"study_design_scores_gemma":[0.002861003,0.00157481,0.001478625,0.00001994731,0.00002569982,0.000005877448,0.00009390824,0.00061369,0.9894344,0.000115911,0.003585683,0.000190464],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","genre_codex":"empirical","genre_gemma":"empirical","genre_scores_codex":[0.9420884,0.004472226,0.05260883,0.00006233062,0.000122474,0.0005235572,0.00004725951,0.00001115636,0.00006380914],"genre_scores_gemma":[0.9977189,0.001153867,0.0005673406,0.0001127617,0.00009063455,0.00005467936,0.0001729879,0.00004706682,0.00008175999],"genre_candidate":"empirical","genre_consensus":"empirical","teacher_disagreement_score":0.05563054,"threshold_uncertainty_score":0.803449,"prediction_status":"machine_predicted_unvalidated"},"machine_scores":{"provisional":true,"baseline":true,"maturity_gate_passed":false,"score_opus":0.01623556330567264,"score_gpt":0.2684109666541969,"score_spread":0.2521754033485242,"validation_status":"score_only:v0-immature-baseline","note":"Baseline scores from an immature model (maturity gate not passed). Scores rank; they never assert a category."}}